McLean K - Search Results

1

Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival.

Silva IA, Bai S, McLean K, Yang K, Griffith K, Thomas D, Ginestier C, Johnston C, Kueck A, Reynolds RK, Wicha MS, Buckanovich RJ. Silva IA, et al. Among authors: mclean k. Cancer Res. 2011 Jun 1;71(11):3991-4001. doi: 10.1158/0008-5472.CAN-10-3175. Epub 2011 Apr 15. Cancer Res. 2011. PMID: 21498635 Free PMC article.

2

Myeloid cells functioning in tumor vascularization as a novel therapeutic target.

McLean K, Buckanovich RJ. McLean K, et al. Transl Res. 2008 Feb;151(2):59-67. doi: 10.1016/j.trsl.2007.11.002. Epub 2007 Dec 26. Transl Res. 2008. PMID: 18201673 Review.

3

Identifying alemtuzumab as an anti-myeloid cell antiangiogenic therapy for the treatment of ovarian cancer.

Pulaski HL, Spahlinger G, Silva IA, McLean K, Kueck AS, Reynolds RK, Coukos G, Conejo-Garcia JR, Buckanovich RJ. Pulaski HL, et al. Among authors: mclean k. J Transl Med. 2009 Jun 19;7:49. doi: 10.1186/1479-5876-7-49. J Transl Med. 2009. PMID: 19545375 Free PMC article.

4

Human ovarian carcinoma–associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production.

McLean K, Gong Y, Choi Y, Deng N, Yang K, Bai S, Cabrera L, Keller E, McCauley L, Cho KR, Buckanovich RJ. McLean K, et al. J Clin Invest. 2011 Aug;121(8):3206-19. doi: 10.1172/JCI45273. J Clin Invest. 2011. PMID: 21737876 Free PMC article.

5

BMPs morph into new roles in ovarian cancer.

McLean K, Buckanovich RJ. McLean K, et al. Cell Cycle. 2013 Feb 1;12(3):389. doi: 10.4161/cc.23553. Epub 2013 Jan 16. Cell Cycle. 2013. PMID: 23324340 Free PMC article.

6

A novel model for evaluating therapies targeting human tumor vasculature and human cancer stem-like cells.

Burgos-Ojeda D, McLean K, Bai S, Pulaski H, Gong Y, Silva I, Skorecki K, Tzukerman M, Buckanovich RJ. Burgos-Ojeda D, et al. Among authors: mclean k. Cancer Res. 2013 Jun 15;73(12):3555-65. doi: 10.1158/0008-5472.CAN-12-2845. Epub 2013 Apr 10. Cancer Res. 2013. PMID: 23576551 Free PMC article.

7

Effects of morcellation of uterine smooth muscle tumor of uncertain malignant potential and endometrial stromal sarcoma: case series and recommendations for clinical practice.

Mowers EL, Skinner B, McLean K, Reynolds RK. Mowers EL, et al. Among authors: mclean k. J Minim Invasive Gynecol. 2015 May-Jun;22(4):601-6. doi: 10.1016/j.jmig.2015.01.007. Epub 2015 Jan 14. J Minim Invasive Gynecol. 2015. PMID: 25596464

8

CD24+ Ovarian Cancer Cells Are Enriched for Cancer-Initiating Cells and Dependent on JAK2 Signaling for Growth and Metastasis.

Burgos-Ojeda D, Wu R, McLean K, Chen YC, Talpaz M, Yoon E, Cho KR, Buckanovich RJ. Burgos-Ojeda D, et al. Among authors: mclean k. Mol Cancer Ther. 2015 Jul;14(7):1717-27. doi: 10.1158/1535-7163.MCT-14-0607. Epub 2015 May 12. Mol Cancer Ther. 2015. PMID: 25969154 Free PMC article.

9

Human carcinoma-associated mesenchymal stem cells promote ovarian cancer chemotherapy resistance via a BMP4/HH signaling loop.

Coffman LG, Choi YJ, McLean K, Allen BL, di Magliano MP, Buckanovich RJ. Coffman LG, et al. Among authors: mclean k. Oncotarget. 2016 Feb 9;7(6):6916-32. doi: 10.18632/oncotarget.6870. Oncotarget. 2016. PMID: 26755648 Free PMC article.

10

Perioperative Laboratory Abnormalities in Gynecologic Oncology Surgical Patients.

Burnett TL, Junn J, Kolenic GE, Christen C, Johnston CM, Reynolds RK, McLean K. Burnett TL, et al. Among authors: mclean k. J Gynecol Surg. 2016 Apr 1;32(2):111-118. doi: 10.1089/gyn.2015.0106. J Gynecol Surg. 2016. PMID: 27041975 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,011 results

Search Page

Filters